Insider Transactions in Q1 2025 at Anaptysbio, Inc (ANAB)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,217
-16.77%
|
$33,255
$15.3 P/Share
|
|
Jan 06
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,545
+29.55%
|
-
|
|
Jan 06
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,054
-12.95%
|
$30,810
$15.3 P/Share
|
|
Jan 06
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,245
+24.86%
|
-
|
|
Jan 06
2025
|
Paul F. Lizzul Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,261
-8.1%
|
$33,915
$15.3 P/Share
|
|
Jan 06
2025
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,145
+18.05%
|
-
|
|
Jan 06
2025
|
Daniel Faga President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,387
-1.44%
|
$95,805
$15.3 P/Share
|
|
Jan 06
2025
|
Daniel Faga President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,850
+3.87%
|
-
|
|
Jan 03
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,994
-28.06%
|
$41,916
$14.6 P/Share
|
|
Jan 03
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,288
+40.59%
|
-
|
|
Jan 03
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,407
-24.3%
|
$47,698
$14.6 P/Share
|
|
Jan 03
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,293
+37.17%
|
-
|
|
Jan 03
2025
|
Paul F. Lizzul Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,336
-16.62%
|
$60,704
$14.6 P/Share
|
|
Jan 03
2025
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,555
+28.8%
|
-
|
|
Jan 03
2025
|
Daniel Faga President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,033
-2.98%
|
$182,462
$14.6 P/Share
|
|
Jan 03
2025
|
Daniel Faga President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,678
+7.34%
|
-
|
|
Jan 02
2025
|
Eco R1 Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
6,646
+0.08%
|
$79,752
$12.95 P/Share
|